STAMBAUGH LARRY G 4
4 · MAXIM PHARMACEUTICALS INC · Filed Jan 6, 2006
Insider Transaction Report
Form 4
STAMBAUGH LARRY G
DirectorChairman,CEO and President
Transactions
- Disposition to Issuer
Common Stock
2006-01-04−3,657→ 0 total - Disposition to Issuer
Common Stock
2006-01-04−10,000→ 0 total(indirect: By Spouse)
Footnotes (1)
- [F1]Disposed of pursuant to an Agreement and Plan of Merger among issuer, EpiCept Corporation and Magazine Acquisition Corp., dated September 6, 2005, in exchange for 0.203969 shares of EpiCept common stock and cash for fractional shares of EpiCept common stock equal to approximately $1.134 per share. Because there was no public market for the EpiCept common stock at the effective time of the merger, the market value of such stock was not determinable.